Home Blog

[Latest] Global Breathable Films Market Size/Share Worth USD 4.8 Billion by 2030 at an 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

0

<!– Name:DistributionId Value:8738340 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2791 –> <!– Name:CustomerId Value:1262785 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:6cf599f3-7000-433f-b0b0-1b486decce1e –>

Sandy, Utah, USA, Jan. 29, 2023 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “Breathable Films Market Size, Trends, and Insights By Material (Polypropylene, Polyethylene, Others), By Technology (Microporous, Monolithic), By End User (Medical, Packaging, Textile, Construction, Hygiene and personal care, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share Outlook, and Forecast 2022–2030” in its research database.

“According to the latest research study, the demand for global Breathable Films Market size & share was valued at approximately USD 2.8 Billion in 2021 and is expected to reach USD 3.2 billion in 2022 and is expected to reach a value of around USD 4.8 Billion by 2030, at a compound annual growth rate (CAGR) of about 8% during the forecast period 2022 to 2030.”

The increasing demand for hygiene among the people has emerged as a major growth factor for the breathable film market and is expected to increase.

The huge demand for products that help maintain hygiene in the healthcare sector and the food packaging industry has emerged as the major driving force for the market’s growth. The high disposable income available to the people has enabled them to opt for advanced options available in the market. The pandemic outbreak considerably impacted this market as the demand for premium materials had increased worldwide, with the high demand for PPE kits.

Click Here to Access a Free Sample Report of the Global Breathable Films Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=18719

Market Dynamics

Drivers

The increasing demand for hygiene products among developing countries has emerged as a major driving force for the breathable films market, which is expected to grow similarly in the future and hence record considerable revenue over the period. The extensive use of breathable films by the packaging industry has emerged as a major growth factor for the market due to the huge demand for premium packaging materials among consumers. 

The higher disposable income available to the people has enabled them to opt for premium packaging materials and advanced healthcare facilities that have helped the market record considerable revenue over the period.

Restraints

The breathable film market’s growth has declined due to the lack of penetration it has exhibited regarding the use of baby diapers. The high cost associated with using premium breathable materials has imposed additional pressure on the key market players, as it will emerge as a major obstacle to the market’s growth during the forecast period. These multiple reasons have emerged as the restraining factors for the market’s growth.

(A free sample of the Breathable Films report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 220+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on the Request
  • Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2022
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis 
  • Custom Market Insights (CMI) research methodology

(Please note that the sample of the Breathable Films report has been modified to include the COVID-19 impact study prior to delivery.)

Request Customized Sample Copy of Breathable Films Market Report @ https://www.custommarketinsights.com/request-for-customization/?reportid=18719

Opportunities

The increasing awareness regarding hygiene and health among the people, mainly after the pandemic outbreak, has emerged as a major opportunity for the growth of the breathable films market and is expected to continue similarly in the future. The demand is steadily increasing worldwide about the increasing demand for advanced health care facilities among the people. The food and beverages industry, along with the healthcare sector, has emerged as a major opportunity for the growth of the breathable film market.

Challenges

The cultural barriers worldwide vary according to the region, which emerges as a major challenge for the growth of the breathable films market. Lack of awareness regarding feminine hygiene among people in certain parts of the world has emerged as a major challenging factor for the growth of the market. Certain materials have been restricted as they are considered taboo, which imposes additional pressure on the key market players.

Report Highlights

Based on Material, the segment of polyethene has emerged as the largest market all over the world pertaining to the extensive use of this Material for the manufacturing process of multiple products due to the premium experience that is provided with the help of this Material. Based on Technology, the monolithic technology segment has emerged as the largest market with extensive demand for this particular Technology among the key market players. Based on end-user, the segment of hygiene and personal care has emerged as the largest market for the extensive demand for baby diapers and adult diapers used in the healthcare sector regularly.

The heavy consumption of surgical drapes in the healthcare sector has also emerged as a major growth factor for this particular segment. Based on geography, the region of Asia Pacific has emerged as the largest market for this particular product because of the increasing awareness regarding hygiene and the rapid use of breathable films in the packaging industry, mainly in China.

Request Customized Sample Copy of Breathable Films Market Report @ https://www.custommarketinsights.com/report/breathable-films-market/

Key questions answered in this report:

  • What is the size of the Breathable Films market and what is its expected growth rate?
  • What are the primary driving factors that push the Breathable Films market forward?
  • What are the Breathable Films Industry’s top companies?
  • What are the different categories that the Breathable Films Market caters to?
  • What will be the fastest-growing segment or region?
  • In the value chain, what role do essential players play?
  • What is the procedure for getting a free copy of the Breathable Films market sample report and company profiles?

Key Offerings:

  • Market Share, Size & Forecast by Revenue | 2022−2030
  • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
  • Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by Regions
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Directly Purchase a copy of the report [220+ Pages] @ https://www.custommarketinsights.com/report/breathable-films-market/

Regional Snapshots

The geographical region of Asia Pacific has emerged as the largest market for breathable films about the huge demand experienced by the food packaging industry, which uses this Material on a large scale to provide a premium packaging experience to potential consumers. The medical industry also makes use of this particular Material for helping patients who suffer from incontinence which mainly includes people belonging to the geriatric population. The huge number of people who belong to this geographic population account for the largest market share and is expected to continue similarly in the future.

The increasing disposable income has enabled them to opt for advanced medical facilities that provide a premium experience to potential consumers. The region of China has emerged as a major consumer of breathable films of the huge packaging industry that belongs to this region. The extensive use of baby diapers has also emerged as a major reason for the growth of the present market. Consumption of breathable films in North America and Europe is increasing considerably and is expected to boost the market growth tremendously in the coming times.

Click Here to Access a Free Sample Report of the Global Breathable Films Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=18719

Report Scope

Feature of the Report Details
Market Size in 2021 USD 2.8 billion
Projected Market Size in 2030 USD 4.8 billion
CAGR Growth Rate 8% CAGR
Base Year 2021
Forecast Period 2022-2030
Prominent Players LyondellBasell Industries N.V., Kimberly-Clark Corporation, Berry Globaal Inc., DuPont de Nemours Inc., Daika Kogyo Co. Ltd., Fujian Xingyuan Industry Co. Ltd., Schweitzer-Mauduit International Inc., Rahil Foam Pvt. Ltd., Toray Industries Inc., Mitsui Chemicals Inc., Innovia Films, RKW Group, Nitto Denko Corporation, Trioplast Industries AB, Fatra A.S., Covestro AG, Skymark Packaging, American Polyfilm, Arkema Group, Omya AG, and Others
Key Segment By Material (Polypropylene, Polyethylene, Others), By Technology (Microporous, Monolithic), By End User (Medical, Packaging, Textile, Construction, Hygiene and personal care, Others), and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors, and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfill your requirements for research.

Key Players

  • LyondellBasell Industries N.V.
  • Kimberly-Clark Corporation
  • Berry Globaal Inc.DuPont de Nemour Inc.
  • Daika Kogyo Co. Ltd.
  • Fujian Xingyuan Industry Co. Ltd.
  • Schweitzer-Mauduit International, Inc.
  • Rahil Foam Pvt. Ltd.
  • Toray Industries Inc.
  • Mitsui Chemicals Inc.
  • Innovia Films
  • RKW Group
  • Nitto Denko Corporation
  • Trioplast Industries AB
  • Fatra A.S.
  • Covestro AG
  • Skymark Packaging
  • American Polyfilm
  • Arkema Group
  • Omya AG
  • Others

Request Customized Copy of Breathable Films Market Report @ https://www.custommarketinsights.com/report/breathable-films-market/

(We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)

Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? 

Email Directly Here with Detail Information: [email protected]

Browse the full “Breathable Films Market Size, Trends, and Insights By Material (Polypropylene, Polyethylene, Others), By Technology (Microporous, Monolithic), By End User (Medical, Packaging, Textile, Construction, Hygiene and personal care, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share Outlook, and Forecast 2022–2030” Report at https://www.custommarketinsights.com/report/breathable-films-market/


Recent Developments

  • Berry Global, in January 2020, did announce capacity expansion worth US$ 20 Mn for breathable and sustainable films. As such, the company would expand its hygiene, healthcare, and speciality film platform across North America.

Segments covered in this report

By Material

  • Polypropylene
  • Polyethylene
  • Others

By Technology

  • Microporous
  • Monolithic

By End User

  • Medical
  • Packaging
  • Textile
  • Construction
  • Hygiene and personal care
  • Others

On the basis of Geography

North America

  • The U.S.
  • Canada
  • Mexico

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Click Here to Access a Free Sample Report of the Global Breathable Films Market @ https://www.custommarketinsights.com/report/breathable-films-market/

Key Insights from Primary Research/Key Insights & Findings from the report:

  • As per the analysis shared by our primary respondents, the Breathable Films market is expected to grow annually at a CAGR of around 10.5 %.
  • Through primary research, it was established that the Breathable Films market was valued at around USD 1.5 Billion in 2021.
  • Based on type segmentation, gas chromatography (GC) and high-performance liquid chromatography (HPLC) were predicted to show maximum market share in the year 2021.
  • The key factor driving the market is the legalization of cannabis use for recreational and medical purposes will be the primary force behind future market trends.
  • The “North America” region will lead the global Breathable Films market during the forecast period 2022 to 2030.

Spectacular Deals

  • Comprehensive coverage
  • Maximum number of market tables and figures
  • Subscription-based option offered
  • Best price guarantee
  • Free 35% or 60 hours of customization.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantees are available.
  • Personalized market brief by author.

Click Here to Get a Free Sample Report of the Global Breathable Films Market @ https://www.custommarketinsights.com/report/breathable-films-market/

Browse More Related Reports: 

Nano Zinc Oxide Market: Nano Zinc Oxide Market Size, Trends and Insights By Product Type (Coated Nano Zinc Oxide, Uncoated Nano Zinc Oxide), By Application (Personal Care and Cosmetics, Healthcare, Agriculture, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030

Breathable Films Market: Breathable Films Market Size, Trends, and Insights By Material (Polypropylene, Polyethylene, Others), By Technology (Microporous, Monolithic), By End User (Medical, Packaging, Textile, Construction, Hygiene and personal care, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share Outlook, and Forecast 2022–2030

Foamed Plastic Insulation Products Market: Foamed Plastic Insulation Products Market Size, Trends and Insights By Type (Polyurethane Foam, Polystyrene, Polyisocyanurate, Phenolic Foam, Other), By Application (Building & Construction, Industrial, Residential, Other), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030

Fibre Reinforced Plastic Pipes Market: Fibre Reinforced Plastic Pipes Market Size, Trends and Insights By Type (Glass fibre, Carbon fibre, Aramid, Basalt), By End-User (Oil & Gas industry, Chemical industry, Sewage industry, Irrigation industry, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030

High Strength Concrete Market: High Strength Concrete Market Size, Trends and Insights By Product Type “(Ready-mix/Pre-mix, Precast concrete, On-site), By Application (Underground Construction, Inground swimming pool Commercial, Residential, Infrastructure, Other Applications), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030

This Breathable Films Market Research/Analysis Report Contains Answers to the following Questions.

  • Which Manufacturing Technology is used for Breathable Films? What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?
  • Who Are the Global Key Players in This Breathable Films Market? What are Their Company Profile, Product Information, and Contact Information?
  • What Was the Global Market Status of the Breathable Films Market? What Was the Breathable Films Market’s Capacity, Production Value, Cost and PROFIT?
  • What Is the Current Market Status of the Breathable Films Industry? What’s Market Competition in This Industry, Both Company and Country Wise? What’s Market Analysis of the Breathable Films Market by Taking Applications and Types in Consideration?
  • What Are Projections of the Global Breathable Films Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports?
  • What Is Breathable Films Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
  • What Is the Economic Impact On the Breathable Films Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
  • What Are the Market Dynamics of the Breathable Films Market? What Are Challenges and Opportunities?
  • What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Breathable Films Industry?

Reasons to Purchase Breathable Films Market Report

  • Breathable Films Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors.
  • The Breathable Films Market report outlines market value (USD) data for each segment and sub-segment.
  • This report indicates the region and segment expected to witness the fastest growth and dominate the market.
  • Breathable Films Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region.
  • The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled.
  • Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players.
  • The Industry’s current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions.
  • Breathable Films Market Includes in-depth market analysis from various perspectives through Porter’s five forces analysis and provides insight into the market through Value Chain.

Click Here to Access a Free Sample Report of the Global Breathable Films Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=18719

Reasons for the Research Report

  • The study provides a thorough overview of the global Breathable Films market. Compare your performance to that of the market as a whole.
  • Aim to maintain competitiveness while innovations from established key players fuel market growth.

What does the report include?

  • Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Breathable Films market analysis.
  • The competitive environment of current and potential participants in the Breathable Films market is covered in the report, as well as those companies’ strategic product development ambitions.
  • According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions.
  • For each segment mentioned above, actual market sizes and forecasts have been given.

Who should buy this report?

  •  Participants and stakeholders worldwide Breathable Films market should find this report useful. The research will be useful to all market participants in the Breathable Films industry.
  •  Managers in the Breathable Films sector are interested in publishing up-to-date and projected data about the worldwide Breathable Films market.
  •  Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Breathable Films products’ market trends.
  •  Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. 

Request Customized Sample Copy of Breathable Films Market Report @ https://www.custommarketinsights.com/report/breathable-films-market/

About Custom Market Insights:

Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.

CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.

Follow Us on LinkedInhttps://www.linkedin.com/company/custom-market-insights/

 Follow Us on Twitterhttps://twitter.com/custommarketins

 Follow Us on Facebookhttps://www.facebook.com/cmarketinsights

Contact Us:

 Joel John

 USA: +1 801-639-9061

 India: +91 20 46022736

 Email: [email protected]

 Web: https://www.custommarketinsights.com/

Blog: https://www.techyounme.com/

Blog: https://atozresearch.com/

Blog: https://www.technowalla.com/

Blog: https://marketresearchtrade.com/

Directly Purchase a copy of the report [220+ Pages] @ https://www.custommarketinsights.com/report/breathable-films-market/

CENTR Brands Announces Share Payment to Hybrid Financial Ltd.

0

Vancouver, British Columbia–(Newsfile Corp. – January 27, 2023) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (“CENTR” or the “Company”). Pursuant to the previously announced Marketing Agreement dated December 2, 2021 (the “Agreement”), Hybrid Financial Ltd. (“Hybrid”) was engaged to provide marketing services to CENTR. CENTR is pleased to announce it has issued shares at a price of $0.50 per share to Hybrid for its services, totaling 567,000 shares, in full satisfaction of the amount owing to Hybrid for the services it performed under the Agreement.

With this share payment to Hybrid, CENTR and Hybrid have completed their initial marketing arrangement. CENTR has a number of exciting initiatives during calendar year 2023, including new product launches, and will look forward to continuing to share its exciting growth story with the market in this new year, including both existing and prospective shareholders.

About CENTR Brands Corp.
CENTR Brands Corp. is one of North America’s leading functional wellness beverage companies. The Company develops and markets non-alcoholic, functional beverages and powders for the global market. The Company produces CENTR and CENTR Sugar Free, both sparkling, low calorie CBD beverages; CENTR Instant, a family of on-the-go, adaptogen-based CBD powders; and CENTR Enhanced, a refreshing, ZERO calorie, nootropic and adaptogen, non-CBD sparkling functional beverage incorporating a variety of science-backed ingredients.

For more information on CENTR Brands, visit findyourcentr.com or contact us at [email protected]. Be sure to follow us on social media @findyourcentr and @drinkcentr. Consumers that do not yet have a local CENTR Brands retailer can visit our online store at: www.findyourcentr.com.

On behalf of the Board,

CENTR BRANDS CORP.
/s/ Arjan Chima
Arjan Chima, Chief Executive Officer

This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Forward-looking statements are not comprised of historical facts. Forward-looking statements include estimates ​and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the ​Company or management expects a stated condition or result to occur. Forward-looking statements may be ​identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or ​​”plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by ​their very nature they involve inherent risks and uncertainties. Although these statements are based on information ​currently available to the Company, the Company provides no assurance that actual results will meet management’s ​expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual ​events, results, performance, prospects and opportunities to differ materially from those expressed or implied by ​such forward-looking information​. Forward looking information in this news release includes, but is not limited to, the Company’s intentions regarding ​its objectives, goals or future plans and statements, including with respect to the value proposition the Company offers to consumers, the Company’s ability to capitalize on global health & wellness trends, its ability to grow revenue opportunities and improve returns to its shareholders, the Company’s positioning in the emerging health beverage market and the Company’s ability to drive sustainable, industry-leading growth.​ Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152808

Halo Collective Reports Q4 Revenue Increase For its Budega(TM) Retail Stores in California

0

Toronto, Ontario–(Newsfile Corp. – January 27, 2023) – Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9K0) (“Halo” or the “Company”) a vertical integrated cannabis company, is pleased to report preliminary unaudited revenue numbers for its California operations, with retail sales increasing 16.8% for this last quarter[1]. The Company has made progress with its Budega™ VIP Program and its new location in Hollywood expected to open this year. The Company is evaluating new sales and marketing initiatives through a series of pop-ups across California which will act as a pre-requisite to the continued expansion of the Budega™ retail chain testing the demand in various regions within the state.

The Company has continually increased revenues in the retail division of its California operations each quarter, contributing over $1.4M to the top line revenues for 2022[2]. The Company expects a continued increase of retail store revenues after launching new marketing initiatives and prepares for an additional revenues stream from its third dispensary location opening later this year. BDSA projects US recreational and medical cannabis will be $46B by 2026, with California remaining the largest market and constituting over 50% of legal sales[3]. Another estimate has legal retail sales in the US growing to $52.6B by 2026.[4] With reduced capacity across the state[5] and larger players exiting[6], the Company believes its operations in California will continue delivering results in the years to come.

The following initiatives have been launched in a series of marketing efforts to increase top-lines revenues:

  • The Budega™ VIP Program will be available at all Budega™ locations for customers to participate in a loyalty points program. The special membership program includes a discounted rate to it high-value customers and will integrate a software program to allow efficient tracking of customer purchases. The Company will access purchase data to adjust promotional targeting accordingly.
  • A guerrilla marketing approach through a series of pop-ups across California. The incentive will act as a pre-requisite to the continued expansion of the Budega™ retail chain, testing the demand in various regions within the state while generating additional revenues.

The Company has been discussing innovative ways to connect with the community. Pop-up shops have been growing in recent years, with many brands opening short-term retail locations in cities around the world. In the modern experience economy, creating an environment where customers can touch, see and smell things creates a memorable experience. Instead of just skimming through racks or browsing items online, really experiencing a carefully selected inventory can help items stand out in shoppers’ minds. Only being able to see the items for three days a month also adds a sense of urgency and exclusivity to the items, which can be a huge draw for customers.[7] Halo is in discussion for obtaining multiple event-based cannabis licenses to launch a series of pop-ups across California which will allow the Company to test the market acceptance in high traffic areas and communities in preparation for its retail expansion plans.

“The California cannabis market continues to deliver a large legal recreational consumer base and Halo intends to keep up with the state’s evolving market trends. We will continue to assess the effectiveness the proposed pop-up incentive as we test different pockets in the state. Our Budega™ retail revenue growth has proven to be strong since the initial launch, and we expect to see this arm of the Company contribute to top line revenues as we expand into new locations,” commented Katie Field, Chairman and Chief Executive Officer of Halo Collective.

The Company has obtained the state retail license for the Hollywood location and has been moving through necessary steps on construction and build out for the new opening.

About Halo Collective

Halo is focused on the United States West Coast, where it has vertically integrated operations covering the entire value chain from seed to sale. Halo cultivates, extracts, manufactures, and distributes quality cannabis flower, pre-rolls, vape carts, edibles, and concentrates. Halo sells these products under a portfolio of brands, including Hush™, Winberry Farms™, its retail brand Budega™, and license agreements with FlowerShop*. In addition, Halo has opened two dispensaries in Los Angeles under the Budega™ brand in North Hollywood and Hollywood, with plans to open one more in Hollywood in 2023.

In the non-THC sector, Halo is expanding into health and wellness categories, including CBD and functional supplements. Halo, through a series of acquisitions, has product offerings in the form of beverages (H2C Beverages) and dissolvable strips (Dissolve Medical).

Halo has successfully acquired and integrated a variety of companies which were subsequently reorganized to create Akanda Corp. (NASDAQ: AKAN), an international medical cannabis and wellness company, of which Halo is the largest shareholder. Halo has also acquired a range of software development assets, including CannPOS, Cannalift, CannaFeels, and a discrete sublingual dosing technology, Accudab. Halo intends to reorganize these entities (including their intellectual property and patent applications) into a subsidiary called Halo Tek Inc. and to complete the distribution of the shares of Halo Tek Inc. to shareholders on record at a date to be determined.

For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com.

Connect with Halo Collective: Email | Website | LinkedIn | Twitter | Instagram

Contact Information

Halo Collective Inc.
Investor Relations
[email protected]
www.haloco.com/investors

For additional information please contact Marshall Minor, Interim Chief Financial Officer of the Company at (541) 646-5694 or [email protected]

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Halo’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Halo’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking information may relate to anticipated events or results including, but not limited to expectations regarding improved performance, management’s plans regarding Pistil Point and the California market, plans regarding streamlining of business segments, management’s plans regarding its portfolio of cannabis businesses and intention to expand into health and wellness, the proposed distribution agreement with SWAY Energy Corporation, the expected opening date of the Company’s California dispensaries and the proposed spin-off by Halo Tek Inc.

By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions. Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: inability of management to successfully integrate the operations of acquired businesses, changes in the consumer market for cannabis products, changes in the expected outcomes of the proposed changes to Halo’s operations, delays in obtaining required licenses or approvals necessary for the build-out of Oregon operations, dispensaries or Canadian operations, the proposed spin-out with Halo Tek Inc., delays or unforeseen costs incurred in connection with construction, the ability of competitors to scale operations in Northern California, delays or unforeseen difficulties in connection with the cultivation and harvest of Halo’s raw material, changes in general economic, business and political conditions, including changes in the financial markets; and the other risks disclosed in the Company’s annual information form dated March 31, 2022 and other disclosure documents available on the Company’s profile at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected.

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Halo does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Halo or persons acting on its behalf is expressly qualified in its entirety by this notice.

Non-Solicitation

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.


[1] The 16.8% percentage has been calculated based on preliminary unaudited revenue numbers.
[2] The $1.4M revenue has been calculated based on preliminary unaudited revenue numbers.
[3] https://bdsa.com/wp-content/uploads/2022/05/BDSA_Cannabis-by-the-Numbers_Beer-Marketers-Insights-Presentation_May-2022-1.pdf
[4] https://mjbizdaily.com/marijuana-industry-will-add-nearly-100-billion-to-us-economy-in-2022/
[5] https://mjbizdaily.com/cannabis-growers-exit-california-market-helping-stabilize-prices/
[6] https://www.newcannabisventures.com/curaleaf-exits-three-western-states/
[7]https://www.forbes.com/sites/blakemorgan/2019/06/03/pop-ups-are-an-adrenaline-shot-for-retail/?sh=2263a9396e65

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152743

Copland Road Capital Announces Closing of Oversubscribed Private Placement

0

Vancouver, British Columbia–(Newsfile Corp. – January 27, 2023) – Copland Road Capital Corporation (CSE: CRCC) (“Copland Road” or the “Company“) is pleased to announce it has completed a non-brokered private placement financing (the “Offering“) through the issuance of 2,713,500 common shares (the “Common Shares“) in the capital of the Company at a price of $0.25 per Common Share for gross proceeds of $678,375.

The gross proceeds raised from the Offering will be used for working capital and general corporate purposes. The securities issued upon closing of the Offering will be subject to a hold period of four months plus a day from the date of closing, pursuant to applicable securities laws. The closing of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the approval of the Canadian Securities Exchange.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The Offering constituted a related party transaction within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“) insiders of the Company subscribed for an aggregate of 783,500 Common Shares pursuant to the Offering. The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(b) and 5.7(1)(a) of MI 61-101, as the Company is not listed on a specified market and the fair market value of the participation in the Offering by the insiders does not exceed 25% of the market capitalization of the Company in accordance with MI 61-101. The Company did not file a material change report in respect of the related party transaction at least 21 days before the closing of the of the Offering, which the Company deems reasonable in the circumstances in order to complete the Offering in an expeditious manner. As a result of participating in the Offering, Mr. Kelly’s holdings increased to approximately 10.45% of the Company’s issued and outstanding Common Shares on a non-diluted basis and approximately 10.75% of the Company’s issued and outstanding Common Shares on a partially basis. A copy of the early warning report will be available on the Company’s issuer profile on SEDAR at www.sedar.com.

About Copland Road Capital Corporation

Copland Road is a Canadian investment firm that invests in assets across multiple industries, with the aim of creating tangible value for its shareholders.

For more information, please visit https://copland-road.com

For inquiries, please contact:
Bruce Langstaff, Executive Chairman
[email protected]
(647) 242-4258

Forward-Looking Statements

This news release includes certain “forward-looking statements” within the meaning of that phrase under Canadian securities laws. Without limitation, statements regarding future plans and objectives of the Company are forward-looking statements that involve various degrees of risk. Forward-looking statements reflect management’s current views with respect to possible future events and conditions and, by their nature, are based on management’s beliefs and assumptions and subject to known and unknown risks and uncertainties, both general and specific to the Company. Although the Company believes the expectations expressed in such forward-looking statements are reasonable, undue reliance should not be placed on such information and statements and such statements are not guarantees of future performance and actual results or developments may differ materially from those in our forward-looking statements. Additional information regarding the material factors and assumptions that were applied in making these forward-looking statements as well as the various risks and uncertainties are described in greater detail in the “Risk Factors” section of the annual Management’s Discussion and Analysis of the Company and other continuous disclosure documents and financial statements under its profile available at www.sedar.com. The Company undertakes no obligation to update this forward-looking information except as required by applicable law. The Company relies on litigation protection for forward-looking statements.

Neither the Canadian Securities Purchase nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Purchase) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152691

Quinsam Declares 34th Quarterly Dividend

0

Toronto, Ontario–(Newsfile Corp. – January 27, 2023) – Quinsam Capital Corporation (CSE: QCA) (“Quinsam” or the “Company”) is announcing that the Board of Directors of Quinsam has approved the Company’s 34th consecutive quarterly dividend. The dividend is $0.00125 per share ($0.005 per share per year). The distribution will be paid on February 24, 2023 to shareholders of record on February 3, 2023. This dividend will be designated as an “eligible dividend” for Canadian income tax purposes. Future quarterly dividends will be subject to Board approval. At the recent share price of approximately $0.08, the current dividend yield is approximately 6.25%.

About Quinsam Capital Corporation

Quinsam is a merchant bank with a focus on “small cap” investments which it believes are undervalued. We do not invest on behalf of third parties or offer investment advice.

Generally, Quinsam does not believe that individual investments are material events. Quinsam may choose to announce certain investments once the company has finished buying its position because we feel that this information helps investors understand our decision making process. Generally, Quinsam does not announce the sale of investments.

For further information contact:

Roger Dent, CEO
(647) 993-5475
[email protected]

This press release may contain forward-looking statements relating to anticipated future events, results, circumstances, performance or expectations that are not historical facts but instead represent our beliefs regarding future events, which are inherently uncertain. Forward-looking statements can often, but not always, be identified by forward-looking words such as “anticipate”, “believe”, “continue”, “expect”, “goal”, “plan”, “intend”, “estimate”, “may”, “project”, “predict”, “potential”, “target”, and “will” or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance.

By their nature, forward-looking statements require making assumptions which include, among other things, that (i) Quinsam will have sufficient capital to effect its business strategies, (ii) the business strategies will produce the results intended by Quinsam, and (iii) the markets will react and perform in a manner consistent with the business strategies.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated. Quinsam believes that the expectations reflected in the forward-looking information are reasonable but no assurance can be given that these expectations will prove to be correct. Some risks and other factors that could cause actual results to differ materially from those expressed in forward-looking information in this press release include, but are not limited to: cannabis companies Quinsam has invested in obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization; market and general economic conditions of the cannabis sector or otherwise, interest rates, regulatory and statutory developments, the nature of the Company’s investments, the available opportunities and competition for investments, the concentration of our investments in certain industries and sectors, reliance on key personnel, risks affecting investments, management of the growth of the Company, and exchange rate fluctuations. Readers are cautioned that the foregoing list of risks and factors is not exhaustive. Although Quinsam has attempted to identify factors that could cause actual events or results to differ materially from those described in forward-looking information, there may be factors that cause events or results to differ from those intended, anticipated or estimated.

The forward-looking information contained herein is provided as at this date, based upon the opinions and estimates of management and information available to management as at this date. Quinsam does not undertake and specifically disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, unless required by applicable law. Readers are cautioned not to place undue reliance on forward-looking information contained herein.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICE

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152602

The Week in Canadian Press Releases: 10 Stories You Need to See

0

 

With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week’s most newsworthy and popular releases, here’s a recap of some major stories from the week that shouldn’t be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

  1. WeCommerce Signs Definitive Agreement to Combine with Tiny 
    “We are thrilled to merge WeCommerce with Tiny and are grateful for the strong support the transaction has received from our major shareholders. This is a great outcome for all parties as the combined company will have substantially more resources, scale and growth potential for many decades to come,” said Chris Sparling, Co-CEO of Tiny.
  2. SPC Nickel Signs Cooperation Agreement with Vale to Consolidate Ownership of the West Graham and Crean Hill 3 Ni-Cu Deposits, Sudbury, Ontario 
    The Agreement grants SPC Nickel the right to acquire an 100% interest in the surface and mineral rights of the Crean Hill 3 Property as therein described. In consideration, certain rights and royalties will be extended to Vale across the combined Project.
  3. Fiera Capital Corporation Appoints Jean-Guy Desjardins as Chief Executive Officer and Announces Other Leadership Changes
    “I am very confident in our ability to execute our global vision and strategic plan, become more efficient allocators of capital and achieve our next phase of success and growth, while creating sustainable prosperity for our clients. In my functions as Chief Executive Officer, I will be supported by a strong executive team and will continue to count on our greatest competitive advantage, our dedicated and talented teams of investment professionals around the globe,” said Mr. Desjardins.
  4. Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call 
    Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thursday, February 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2023 after the close of markets that same day.
  5. All-New 2023 Honda Accord Arriving at Honda Dealers next Month as Newest Iteration of the Midsize Sedan Benchmark
    The two hybrid-electric powered trims feature Honda’s new, more powerful hybrid-electric system. With 247 lb.-ft of torque, they’re the most powerful Accord hybrids ever while achieving outstanding fuel economy ratings, with up to 5.0 L/100 KM in the city, and 5.3 L/100 KM  combined. Positioned at the top of the Accord line-up they will eventually represent about 50% of annual sales, a key step in Honda’s electrification strategy.
  6. Bell Let’s Talk thanks Canadians, governments and organizations around the country for creating positive change for mental health 
    Bell Let’s Talk Day 2023 celebrated the start of a new era by putting a spotlight on Canadian mental health organizations who are working every day to provide mental health supports and services in communities all across the country. Throughout the day, 30 organizations that are taking action to create positive change shared the incredible work they are doing to help Canadians struggling with their mental health.
  7. Invesco Canada announces changes to its product line 
    Effective immediately, all series of units of this fund are closed to new investments other than investments from investors who as of January 23, 2023 are existing investors of the fund or existing participants of the Invesco Rebalancing Service. The fund will be closed to all investments effective on or about close of business May 3, 2023.
  8. Health-care leaders publish new report and urgent open letter to Canadians
    In an open letter to Canadians also published today, health-care leaders write that “our health-care system belongs to all of us. It is not a possession of politicians, or the property of stakeholders claiming special status to speak in its interest. They are the custodians, the guardians to whom we have entrusted the system’s welfare.”
  9. Neighbourly Appoints Pharmacy Industry Veteran Skip Bourdo as CEO
    “We are thrilled to welcome Skip Bourdo to Neighbourly,” stated Stuart M. Elman, Chair of Neighbourly’s Board of Directors. “Skip is a seasoned pharmacy and healthcare leader with a wealth of operational and M&A experience.  Skip’s impressive track record of driving growth, profitability and operational excellence will be critical as Neighbourly continues on its growth trajectory,” concluded Mr. Elman.
  10. Canadian-made video game designed to help maintain abilities and quality of life for children with rare, degenerative neuromuscular disease
    The Company expects to use the net proceeds from the Offering to maintain and advance the Company’s material properties, acquire properties, plant upgrades, drilling, maintenance and refurbishment, community outreach and communications, licensing and permitting and for general corporate and working capital purposes in the manner as set forth in the preliminary short form prospectus.

Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion

0

San Diego, California–(Newsfile Corp. – January 27, 2023) – Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reported that its Phase 2 clinical trial protocol has received study level approval from a central institutional review board (“IRB”). The Phase 2 study is a planned evaluation of SBI-100 Ophthalmic Emulsion (“OE”) in patients with primary open angle glaucoma or ocular hypertension. SBI-100 OE targets the CB1 receptor, which plays a key role in managing intraocular pressure associated with glaucoma.

An IRB, operating under FDA regulations, is designated to assure, both in advance and by periodic review, that appropriate steps are taken to protect the rights and welfare of human subjects participating in biomedical research. IRBs review research protocols and related materials (e.g. informed consent documents and investigator brochures) and have authority to approve, require modifications in (to secure approval), or disapprove research.

A central IRB review process allows for multiple study sites in a multi-center trial to rely on the review of a single (i.e. central) IRB, rather than using multiple IRBs affiliated with each individual research site. The goal of this centralized process is to increase efficiency and decrease duplicative efforts, while enabling the central IRB to take responsibility for all aspects of IRB oversight for each site participating in the centralized review process.

The next steps require each clinical site to provide their site-specific information for the trial to the IRB. In parallel, each clinical site will be submitting the necessary documentation to the US Drug Enforcement Agency, in collaboration with Skye, to be able to conduct research under the Controlled Substances Act (1973).

“Following the FDA’s authorization of our Investigational New Drug application in December, we are methodically completing the manufacturing steps and clinical planning to initiate this important Phase 2 study of SBI-100 Ophthalmic Emulsion in glaucoma patients in the first half of 2023,” said Punit Dhillon, CEO and Chair of Skye. “The central IRB approval is another significant clinical milestone toward our Phase 2 initiation in the US as we also continue enrollment in our on-going Phase 1 study in Australia.”

SBI-100 OE is a novel synthetically-derived molecule formulated as an eye-drop using a propriety nanoemulsion to improve delivery into the eye. SBI-100 OE displayed favorable results in animal studies as a monotherapy and in combination with standard of care (“SOC”) glaucoma drugs compared to SOC alone and other combinations. The first cohort of healthy participants in Skye’s first-in-human Phase 1 clinical trial in Australia was dosed in December.

About Skye Bioscience
Skye Bioscience is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs. The Company’s lead program, SBI-100 OE, is focused on developing a treatment for glaucoma, the world’s leading cause of irreversible blindness. For more information, please visit: www.skyebioscience.com.

CONTACT
Investor Relations
Email: [email protected]e.com
Phone: (858) 410-0266

FORWARD-LOOKING STATEMENTS
This letter contains forward-looking statements, including statements regarding our product development, business strategy, the timing of clinical trials, and commercialization of cannabinoid-derived therapeutics. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including “anticipated,” “plans,” “goal,” “focus,” “aims,” “intends,” “believes,” “can,” “could,” “challenge,” “predictable,” “will,” “would,” “may” or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment, and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of Skye’s most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152694

cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News

0

Leading CBD company comments on FDA declining to regulate the industry and calling on Congress to create new rules

Charlotte, North Carolina–(Newsfile Corp. – January 26, 2023) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation’s leading, highly trusted, and widely recognized CBD companies, announces their commitment to hold the FDA accountable for years of oversight regarding the establishment of safe regulatory frameworks appropriate for cannabinoids.

Today, the Food and Drug Administration (FDA) issued a statement claiming that they required Congressional support to establish a new framework for CBD products, stating they don’t have the tools to properly regulate under current authorities. The FDA also denied the Natural Products Association (NPA) citizens’ petition filed on behalf of cbdMD requesting rulemaking to allow the marketing of CBD products as dietary supplements.

cbdMD is keenly aware that there are rules and guidelines for providing safe dietary supplement products to consumers. We have adhered to those guidelines through our commitment to third party cGMP certifications, posting current COAs for every product on our site, and significant investment in safety and clinical studies.

“The FDA looks forward to working with Congress to develop a cross-agency strategy for the regulation of these products to protect the public’s health and safety,” a statement made in today’s release by the FDA. We agree that Congress needs to step in and force the FDA to do their job.

“As pioneers of the federally legal hemp industry and public leaders in the research of cannabinoids and their benefits to humans and animals, we will continue to work with Congress to further substantiate the evidence and the legal framework for all cannabinoids to be accessed safely and legally,” says President, Kevin MacDermott, “we have attempted to work through this process with the FDA to no avail, it’s time to start making some real changes here.”

cbdMD, as one of the largest companies in the space, taken on the responsibility to take the safety related to our category to the highest levels. Currently, responsible brands are self-regulating and due to lack of oversight there are still irresponsible brands allowed to exist. It’s the same conversation going on around the pathways forward since 2018. With millions of active monthly American consumers this qualifies at the top of ingredients list within the Natural Products Industry up for regulatory review and safety guidelines to be implemented. Here at cbdMD, we took the stance of leading our category responsibility to the next level by bringing in house Dr. Sibyl Swift, a former FDA Director, to lead us into the next generation for safe product expansion in the Cannabidiol category safely.

There are many other markets globally that have regulated these types of products within their existing framework as well as created additional frameworks to allow continued market development. As an industry we will continue to work together and demand reliability and safety for consumers of cannabinoid products.

“Our go forward plan in response to today’s announcement is to work together next to our best in class competition and rise the tide,” Says MacDermott, “demand these answers for our consumers making up the $4.6 billion cannabis-derived market and get a real high-level committee on this movement that isn’t going anywhere soon.”

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company’s Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified using words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements, including but not limited to expectations on our clinical studies, and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2022, as amended, as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

1 THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CFO
+1 (704) 445-3064
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152641

West Island Brands Announces Appointment of New CFO

0

Toronto, Ontario–(Newsfile Corp. – January 26, 2023) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC Pink: WIBFF) (“West Island” or the “Company”) announces the appointment of Ms. Veronique Laberge, CPA as the new CFO of West Island Brands. Ms. Laberge initially joined the company as a special consultant, please see press release dated December 7, 2022. As Chartered Professional Accountant and Auditor with over 17 years of experience in professional practice Ms. Laberge is a welcome member of the Company management team.

Mr. Gurcharn Deol steps down as Interim CFO effective immediately but remains a member of the board of Directors. We would like to thank him for his years of service to the company.

About West Island
West Island is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture is a Montreal, Quebec based cannabis company. A Health Canada Licence Holder West Island has standard cultivation licence, standard processing, medical sales and sales licences.

For more information on West Island Brands please visit the website at: westislandbrands.com. West Island cannabis products can be found in British Columbia, Saskatchewan, Manitoba, Northwest Territories, Ontario and Quebec.

On behalf of the Board of Directors
WEST ISLAND BRANDS INC.
Boris Ziger
Boris Ziger, CEO

The Company’s public filings are available for review at www.sedar.com and www.thecse.com.

For further information, please contact:
Boris Ziger, CEO at:
Telephone: 416-304-9935
Website: www.westislandbrands.com

Boris Ziger, PDG de :
Téléphone : 416-304-9935
Courriel : [email protected]
Site Web : www.westislandbrands.com

Disclaimer for Forward-Looking Information

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152594

CENTR Brands Announces New Online Store & Launch of CENTR Enhanced Functional Sparkling Water

0

Vancouver, British Columbia–(Newsfile Corp. – January 26, 2023) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (“CENTR” or the “Company”), one of the fastest-growing premium functional wellness drink brands in North America, today announced the expansion of our online store with the addition of CENTR Enhanced, a refreshing, ZERO calorie, non-CBD functional sparkling water aimed at enhancing gut health and cognitive performance. CENTR Enhanced will be caffeine-free and CENTR Enhanced+, provides 60mg of natural caffeine for added energy and focus (collectively, “CENTR Enhanced”).

Cannot view this image? Visit: https://i0.wp.com/grassnews.net/wp-content/uploads/2023/01/centr-brands-announces-new-online-store-launch-of-centr-enhanced-functional-sparkling-water.jpg?w=696&ssl=1

Drink CENTR Home Page

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6356/152585_cb95065a14ff29e6_001full.jpg

Adaptogen and nootropic drinks are quickly becoming a popular trend in the health and wellness industry, as more and more people are looking for natural ways to boost their energy and improve their overall well-being. Many health experts believe that adaptogens can help to balance the body’s hormones, improve the immune system, and promote better sleep while nootropics can improve cognitive performance on a variety of tasks, including memory recall, attention, and decision-making.

“Adaptogens can be a great way to support the body’s natural ability to adapt to stress,” says Arjan Chima, CEO of the Company. “Studies conducted by our suppliers have shown they can help improve energy levels, reduce stress, and promote overall well-being.”

CENTR Enhanced is formulated with health promoting ingredients that have been shown to:

  • Enhance Mood with sustainably farmed, plant-based adaptogens to promote anti-anxiety effects, help increase serotonin, and increase dopamine to boost mood.
  • Boost Brain Function by promoting enhanced cognition and work performance, elevate mood, reduce irritability, promote sense of calmness, reduce stress and improve quality of sleep.
  • Increase Immune Support by promoting nutrient absorption.
  • Reduce Stress with natural non-protein amino acids which promote mental clarity while also reducing stress.
  • Support Memory Recall by supplying nutrition needed for the brain to stay alert and focused while also supporting overall cognitive health.

“CENTR Enhanced is the perfect solution for anyone looking to boost their cognitive abilities,” said Chima. “Whether you’re a student studying for exams, a professional looking to improve your performance at work, or just someone looking to stay sharp, the ingredients inside CENTR Enhanced can help. Our goal is to have consumers incorporate CENTR Enhanced into their daily routine.”

The ingredients are non-GMO, gluten-free, and vegan. We have also completed third-party testing for purity and potency, ensuring the highest quality product for our customers.

CENTR Enhanced responds to the tremendous consumer demand in a global market for functional beverages, which was estimated to be over $140 billion in total sales during 2022 and is estimated to grow to almost $280 billion by 2030.The massive growth is driven by the health-conscious consumers seeking great tasting functional alternatives to sugary drinks and alcohol. Given this massive and growing functional beverage category demand, CENTR will immediately benefit from the hundreds of thousands of retail locations (from small c-stores and filling stations to larger grocery formats) that already have demand for these types of functional beverages in their stores.

CENTR Enhanced will initially be available through the Company’s DTC e-commerce channel at www.drinkcentr.com while we build distribution within both our existing account footprint and on-board new distributor relationships within independent grocers, health food stores, juice bars and cafes.

For more information on how our functional sparkling water, CENTR Enhanced, can benefit your wellness, please visit https://drinkcentr.com

About CENTR Brands Corp.

CENTR Brands Corp. is one of North America’s leading functional wellness beverage companies. The Company develops and markets non-alcoholic, functional beverages and powders for the global market. The Company produces CENTR and CENTR Sugar Free, both sparkling, low calorie CBD beverages; CENTR Instant, a family of on-the-go, adaptogen-based CBD powders; and CENTR Enhanced, a refreshing, ZERO calorie, non-CBD, nootropic and adaptogen sparkling water incorporating a variety of science-backed ingredients.

For more information on CENTR Brands visit www.findyourcentr.com or contact us at [email protected]. Be sure to follow us on social media @findyourcentr and @drinkcentr. Consumers that do not yet have a local CENTR Brands retailer can visit our online store at: www.findyourcentr.com

On behalf of the Board,

CENTR BRANDS CORP.
/s/ Arjan Chima
Arjan Chima, Chief Executive Officer

This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Forward-looking statements are not comprised of historical facts. Forward- looking statements include estimates ​and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the ​Company or management expects a stated condition or result to occur. Forward-looking statements may be ​identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or ​​”plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by ​their very nature they involve inherent risks and uncertainties. Although these statements are based on information ​currently available to the Company, the Company provides no assurance that actual results will meet management’s ​expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual ​events, results, performance, prospects and opportunities to differ materially from those expressed or implied by ​such forward-looking information​. Forward looking information in this news release includes, but is not limited to, the Company’s intentions regarding ​its objectives, goals or future plans and statements, including with respect to the value proposition the Company offers to consumers, the Company’s ability to capitalize on global health & wellness trends, its ability to grow revenue opportunities and improve returns to its shareholders, the Company’s positioning in the emerging health beverage market and the Company’s ability to drive sustainable, industry-leading growth.​ Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152585